4tsq
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
+ | |||
==Crystal structure of FraC with DHPC bound (crystal form III)== | ==Crystal structure of FraC with DHPC bound (crystal form III)== | ||
<StructureSection load='4tsq' size='340' side='right' caption='[[4tsq]], [[Resolution|resolution]] 1.60Å' scene=''> | <StructureSection load='4tsq' size='340' side='right' caption='[[4tsq]], [[Resolution|resolution]] 1.60Å' scene=''> | ||
Line 5: | Line 6: | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=HXG:1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>HXG</scene>, <scene name='pdbligand=PC:PHOSPHOCHOLINE'>PC</scene>, <scene name='pdbligand=SCN:THIOCYANATE+ION'>SCN</scene></td></tr> | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=HXG:1,2-DIHEXANOYL-SN-GLYCERO-3-PHOSPHOCHOLINE'>HXG</scene>, <scene name='pdbligand=PC:PHOSPHOCHOLINE'>PC</scene>, <scene name='pdbligand=SCN:THIOCYANATE+ION'>SCN</scene></td></tr> | ||
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3vwi|3vwi]], [[3wp9|3wp9]], [[4tsl|4tsl]], [[4tsn|4tsn]], [[4tso|4tso]], [[4tsp|4tsp]], [[4tsy|4tsy]]</td></tr> | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[3vwi|3vwi]], [[3wp9|3wp9]], [[4tsl|4tsl]], [[4tsn|4tsn]], [[4tso|4tso]], [[4tsp|4tsp]], [[4tsy|4tsy]]</td></tr> | ||
- | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tsq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tsq OCA], [http://www.rcsb.org/pdb/explore.do?structureId=4tsq RCSB], [http://www.ebi.ac.uk/pdbsum/4tsq PDBsum]</span></td></tr> | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4tsq FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4tsq OCA], [http://pdbe.org/4tsq PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4tsq RCSB], [http://www.ebi.ac.uk/pdbsum/4tsq PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4tsq ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
Line 11: | Line 12: | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
- | + | Pore-forming toxins (PFT) are water-soluble proteins that possess the remarkable ability to self-assemble on the membrane of target cells, where they form pores causing cell damage. Here, we elucidate the mechanism of action of the haemolytic protein fragaceatoxin C (FraC), a alpha-barrel PFT, by determining the crystal structures of FraC at four different stages of the lytic mechanism, namely the water-soluble state, the monomeric lipid-bound form, an assembly intermediate and the fully assembled transmembrane pore. The structure of the transmembrane pore exhibits a unique architecture composed of both protein and lipids, with some of the lipids lining the pore wall, acting as assembly cofactors. The pore also exhibits lateral fenestrations that expose the hydrophobic core of the membrane to the aqueous environment. The incorporation of lipids from the target membrane within the structure of the pore provides a membrane-specific trigger for the activation of a haemolytic toxin. | |
- | + | Structural basis for self-assembly of a cytolytic pore lined by protein and lipid.,Tanaka K, Caaveiro JM, Morante K, Gonzalez-Manas JM, Tsumoto K Nat Commun. 2015 Feb 26;6:6337. doi: 10.1038/ncomms7337. PMID:25716479<ref>PMID:25716479</ref> | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
</div> | </div> | ||
+ | <div class="pdbe-citations 4tsq" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 20:30, 3 August 2016
Crystal structure of FraC with DHPC bound (crystal form III)
|